Form 4 for CTEV Claritev Corp
Accepted 2022-03-03 00:00:00 ET · period of report 2022-03-01 · accession 0001793229-22-000033 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-03 | 2022-03-01 | CTEV | Doctoroff Jeffrey | SVP, GC | A - Grant | $0.00 | +96.1K | 435.5K | +28% | $0 |
| D | 2022-03-03 | 2022-03-01 | CTEV | Doctoroff Jeffrey | SVP, GC | A - Grant | $0.00 | +180.7K | 180.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock | 2022-03-01 | A | A | 96,105 | $0.00 | 435,458 | D | — | — | (F1) Represents a grant of restricted stock units which will vest at a rate of 25% per year on each of March 1, 2023, 2024, 2025 and 2026. |
| 2 | Derivative | Stock Option | 2022-03-01 | A | A | 180,677 | $0.00 | 180,677 | D | $3.75 · — to 2032-03-01 | 180,677 Class A common stock, par value $0.0001 per share | (F2) The grant will vest, and become exercisable, at a rate of 25% per year on each of March 1, 2023, 2024, 2025 and 2026. |